SCHIZOAFFECTIVE DISORDER

This study looks at whether offering financial rewards can help people with schizophrenia, bipolar disorder, or substance use disorder stick to their long-acting injectable medications after being forced into the hospital. About 1,000 participants will either get the financial in…

This study tests whether immersive virtual reality (VR) can be a safe and practical way to help people with schizophrenia improve their thinking skills, reduce symptoms, and function better in daily life. Forty adults with schizophrenia or schizoaffective disorder will either rec…

This study helps adults with schizophrenia, bipolar disorder, or other serious mental illnesses reduce or stop taking anticholinergic medications (like benztropine) when they are no longer needed. These drugs can cause memory problems and other side effects. The goal is to safely…

This study aimed to see if a sublingual film of dexmedetomidine (BXCL501) could quickly reduce agitation in adults with bipolar disorder or schizophrenia visiting the emergency department. It was a single-arm pilot study, but it was withdrawn before enrolling any participants. No…

This study tests whether an accelerated schedule of transcranial magnetic stimulation (TMS) is safe and tolerable for people with psychotic disorders like schizophrenia. Twenty adults aged 18-65 will receive the treatment and be monitored for side effects. The goal is to see if t…

This study is testing whether adding a brain skills training program, called cognitive remediation, to standard early psychosis care helps young adults function better in daily life. The research involves about 117 young people in New York who have recently experienced their firs…

This study tests a new program that combines executive function training (like memory and planning exercises) with cognitive-behavioral social skills training for adults aged 60 and older with schizophrenia or schizoaffective disorder. The goal is to see if the combined approach …